Short-Acting Insulin Market Size, Share & Trends Analysis Report By Drug (Novolog, Humalog, Humulin) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR1594DR | Pages: 110

Market Segmentation

  1. Short-Acting Insulin Market, By Drug 2022-2034 (USD MILLION/ Units)
    1. Novolog
    2. Humalog
    3. Humulin
  2. Regional Short-Acting Insulin Market
    1. North America
      1. North America Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Novolog
        2. Humalog
        3. Humulin
      2. U.S. Short-Acting Insulin Market
        1. U.S. Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      3. Canada Short-Acting Insulin Market
        1. Canada Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
    2. Europe
      1. Europe Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Novolog
        2. Humalog
        3. Humulin
      2. U.K. Short-Acting Insulin Market
        1. U.K. Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      3. Germany Short-Acting Insulin Market
        1. Germany Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      4. France Short-Acting Insulin Market
        1. France Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      5. Spain Short-Acting Insulin Market
        1. Spain Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      6. Italy Short-Acting Insulin Market
        1. Italy Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      7. Russia Short-Acting Insulin Market
        1. Russia Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      8. Nordic Short-Acting Insulin Market
        1. Nordic Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      9. Benelux Short-Acting Insulin Market
        1. Benelux Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      10. Rest of Europe Short-Acting Insulin Market
        1. Rest of Europe Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
    3. APAC
      1. APAC Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Novolog
        2. Humalog
        3. Humulin
      2. China Short-Acting Insulin Market
        1. China Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      3. Korea Short-Acting Insulin Market
        1. Korea Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      4. Japan Short-Acting Insulin Market
        1. Japan Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      5. India Short-Acting Insulin Market
        1. India Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      6. Australia Short-Acting Insulin Market
        1. Australia Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      7. Taiwan Short-Acting Insulin Market
        1. Taiwan Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      8. South East Asia Short-Acting Insulin Market
        1. South East Asia Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      9. Rest of Asia-Pacific Short-Acting Insulin Market
        1. Rest of Asia-Pacific Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
    4. Middle East and Africa
      1. Middle East and Africa Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Novolog
        2. Humalog
        3. Humulin
      2. UAE Short-Acting Insulin Market
        1. UAE Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      3. Turkey Short-Acting Insulin Market
        1. Turkey Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      4. Saudi Arabia Short-Acting Insulin Market
        1. Saudi Arabia Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      5. South Africa Short-Acting Insulin Market
        1. South Africa Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      6. Egypt Short-Acting Insulin Market
        1. Egypt Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      7. Nigeria Short-Acting Insulin Market
        1. Nigeria Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      8. Rest of MEA Short-Acting Insulin Market
        1. Rest of MEA Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
    5. LATAM
      1. LATAM Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
        1. Novolog
        2. Humalog
        3. Humulin
      2. Brazil Short-Acting Insulin Market
        1. Brazil Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      3. Mexico Short-Acting Insulin Market
        1. Mexico Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      4. Argentina Short-Acting Insulin Market
        1. Argentina Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      5. Chile Short-Acting Insulin Market
        1. Chile Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      6. Colombia Short-Acting Insulin Market
        1. Colombia Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
      7. Rest of LATAM Short-Acting Insulin Market
        1. Rest of LATAM Short-Acting Insulin Market By Drug 2022-2034 (USD MILLION/ Units)
          1. Novolog
          2. Humalog
          3. Humulin
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: